Supporting patients and staff to improve patient safety

whitePaper | March 6, 2023

Delivering exceptional member engagement experiences isn’t easy. Members expect seamless, convenient access to support and services in whatever channel they prefer.

whitePaper | August 23, 2022

As the market enters the post-pandemic era, payers and providers are tasked with providing a customer and employee experience that keeps pace with that offered by a new wave of digital-native challengers.

whitePaper | October 1, 2021

Today’s healthcare consumers want to pay their medical bills anywhere, anytime. They’re looking for estimates, payment plan options, and payment mechanisms to be at their fingertips across multiple channels. They can pay for almost anything they desire from their laptops and mobile devices, so why should healthcare be any different? What do providers need to know to build a healthcare payment solution that’s fit for purpose today and into the future? Experian Health’s patient payment experts make seven predictions for healthcare payments that will help providers boost consumer loyalty and revenue.

whitePaper | September 28, 2022

Specialty drugs span a wide range of disease states, from the more prevalent, yet complex, such as multiple sclerosis, to rare and orphan diseases, such as hereditary angioedema (HAE).

whitePaper | June 3, 2022

With increased scrutiny from regulatory agencies, advocacy groups and the public for clinical trial transparency, sponsors are feeling the pressure to ramp up efforts to make their studies more accessible.

whitePaper | January 9, 2020

Radiation therapy is one of the most common treatments used to fight cancer in the U.S., with more than half of cancer patients receiving it either alone or in combination with other medical interventions.1 With the traditional approach to radiation therapy, the dose and schedule is tailored to the tumor type, location, and stage of growth, but only infrequently updated in light of changes after treatment starts. Experts in adaptive therapy are looking to deliver a more personalized treatment strategy guided by the individual patient’s needs.